Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- Check23 days agoChange DetectedThe webpage has been updated to include new identifiers and details related to a study on endometrial cancer, while significant sections describing the study's purpose and inclusion criteria have been removed.SummaryDifference24%
- Check106 days agoChange DetectedThe study 'Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma' has been updated with new details, including an increase in study locations from 166 to 207 and a new estimated last update date of January 20, 2025.SummaryDifference37%
- Check120 days agoChange DetectedThe website has updated its contact list, adding numerous new contacts while removing the previous entries, including specific names and phone numbers, indicating a significant overhaul of the contact information.SummaryDifference50%
- Check142 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check149 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.SummaryDifference1%
- Check164 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference2%
Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.